Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]
NCT ID: NCT00393172
Last Updated: 2019-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
400 participants
INTERVENTIONAL
2006-05-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized clinical trial is studying how well exercise prevents breast cancer in healthy young women.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise in Breast Cancer Survivors
NCT04307407
12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers
NCT03518957
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
NCT00337233
Study of Exercise to Manage Distress During Breast Screening
NCT02468050
Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy
NCT00994279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Compare the changes in urine levels of a stable marker of oxidative stress (F\_2-isoprostanes) in healthy young women who undergo exercise training during 4 menstrual cycles vs no exercise.
Secondary
* Assess the changes in other metabolic factors that explain the association between physical activity and breast cancer, including:
Estrogen metabolism (estrone, estradiol, estriol, 2-OHE\_1, 2-OHE\_2, 2-MeOHE\_1, 2-MeOHE\_2, 4-OHE\_1, 4-OHE\_2 \[as well as ratios of these metabolites\], insulin-like growth factor (IGF)-1 (as well as IGF-binding proteins-1, -2, and -3, insulin, glucose, body composition (including body mass index, lean mass, and body fat \[DEXA scan\]).
OUTLINE: This is a randomized, controlled study. Participants are stratified according to baseline body fat percentage and age (18 to 24 years vs 25 to 30 years). Participants are randomized to 1 of 2 intervention arms.
* Arm I: Participants exercise for 30 minutes 5 times a week. The intensity of exercise is increased every 4 weeks. The exercise regimen continues for up to 4 menstrual cycles.
* Arm II: Participants are observed for 4 menstrual cycles. Participants in both arms undergo 24-hour collection of urine on days 7, 8, and 9 of menstrual cycles 1 and 6. F\_2-isoprostanes are measured via gas chromatography-mass spectrometry (GC/MS). Estrogens are also measured by GC/MS and include E\_1, E\_2, E\_3, 2-OHE\_1, 2-OHE\_2, 4-OHE\_1, 4-OHE\_2, 2-MeE\_1, 2-MeE\_2, 4-MeE\_1, 4-MeE\_2, and 16OHE\_1.
Participants undergo blood collection, body mass measurement by dual-energy x-ray absorptiometry, and a fitness assessment twice during the 6-month study.
PROJECTED ACCRUAL: A total of 400 participants will be accrued.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exercise
5 days per week exercise for 4 months
exercise
5 days per week exercise for 4 months
no exercise
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exercise
5 days per week exercise for 4 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reported menstrual cycle length of 25-35 days within the past 2 months
* Nonsmoker
* Sedentary (exercise \< 3 times weekly within the past 6 months)
* Intact ovaries and uterus
* No history of gynecological problems (e.g., fibroids, endometriosis, polycystic ovary syndrome)
* Female
* Premenopausal
* Body mass index 18.5 to 40
* Stable weight (no changes ≥ 10% within the past year)
Exclusion Criteria
* No plans to become pregnant during study treatment
* No cancer within the past 5 years except for nonmelanoma skin cancers
* No medical condition that would prohibit participation in a vigorous program of weight-bearing aerobic exercise including, but not limited to, any of the following:
* Fibromyalgia
* Chronic fatigue syndrome
* Metabolic disorders
* Recent cardiovascular event
* Orthopedic limitations
* Psychiatric disorders requiring antipsychotic drugs
* No uncontrolled hypertension (systolic blood pressure \[BP\] \> 160 mm Hg and/or diastolic BP \> 99 mm Hg)
* No more than 7 alcoholic beverages per week
* No injected hormonal contraceptive use within the past year
* More than 6 months since prior use of intrauterine device
* More than 3 months since prior oral or patch hormone contraceptives
* No medication that would prohibit participation in a vigorous program of weight-bearing aerobic exercise
18 Years
30 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mindy Kurzer
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota - St. Paul Campus
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Crawford TN, Arikawa AY, Kurzer MS, Schmitz KH, Phipps WR. Cross-sectional study of factors influencing sex hormone-binding globulin concentrations in normally cycling premenopausal women. Fertil Steril. 2015 Dec;104(6):1544-51. doi: 10.1016/j.fertnstert.2015.08.040. Epub 2015 Sep 16.
Arikawa AY, Jakits HE, Flood A, Thomas W, Gross M, Schmitz KH, Kurzer MS. Consumption of a high glycemic load but not a high glycemic index diet is marginally associated with oxidative stress in young women. Nutr Res. 2015 Jan;35(1):7-13. doi: 10.1016/j.nutres.2014.10.005. Epub 2014 Oct 16.
Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64. doi: 10.1158/1055-9965.EPI-12-1325.
O'Dougherty M, Schmitz KH, Hearst MO, Covelli M, Kurzer MS. Dual conversations: body talk among young women and their social contacts. Qual Health Res. 2011 Sep;21(9):1191-204. doi: 10.1177/1049732311405804. Epub 2011 Apr 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMN-0505M69867
Identifier Type: REGISTRY
Identifier Source: secondary_id
FWA00000312-5
Identifier Type: -
Identifier Source: org_study_id
NCT00354718
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.